Hanson A, McClenaghan C, Weng KC, Colijn S, Stratman AN, Halabi CM, Grange DK, Silva JR, Nichols CG.
Category: Nichols CG
Rapid Characterization of the Functional and Pharmacological Consequences of Cantú Syndrome KATP Channel Mutations in Intact Cells (Links to an external site)
Gao J, McClenaghan C, Matreyek KA, Grange DK, and Nichols CG
Subunit gating resulting from individual protonation events in Kir2 channels (Links to an external site)
Maksaev G, Brundl-Jirout M, Stary-Weinzinger A, Zangerl-Plessl E-M, Lee S-J, and Nichols CG
Skeletal muscle delimited myopathy and verapamil toxicity in SUR2 mutant mouse models of AIMS (Links to an external site)
McClenaghan C, Mukadam MA, Roeglin J, Tryon RC, Grabner M, Dayal A, Meyer GA, and Nichols CG
Oxidation Driven Reversal of PIP2-dependent Gating in GIRK2 Channels (Links to an external site)
Lee S-J, Maeda S, Gao J, and Nichols CG
Blockade of TRPV channels by intracellular spermine (Links to an external site)
Maksaev G, Yuan P, and Nichols CG
Glucokinase Inhibition: A Novel Treatment for Diabetes? (Links to an external site)
Remedi MS, and Nichols CG
Conformational plasticity of NaK2K and TREK2 potassium channel selectivity filters (Links to an external site)
Matamoros M, Ng XW, Brettmann JB, Piston DW, and Nichols CG
Personalized therapeutics for KATP-dependent pathologies (Links to an external site)
Nichols CG
A unique high-output cardiac hypertrophy phenotype arising from low systemic vascular resistance in Cantu Syndrome (Links to an external site)
Singh GK, McClenaghan C, Aggarwal M, Gu H, Remedi MS, Grange DK, and Nichols CG